Peak Pharmaceuticals (OTCMKTS:PKPH) Trading Down 46.3% – Should You Sell?

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report)’s stock price traded down 46.3% during trading on Tuesday . The company traded as low as $0.50 and last traded at $0.50. 4,130 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 9,053 shares. The stock had previously closed at $0.93.

Peak Pharmaceuticals Price Performance

The company has a fifty day moving average of $1.61 and a two-hundred day moving average of $2.36.

About Peak Pharmaceuticals

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

See Also

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.